Home LiteratureArticle Details
PMID: 996441 Published · ppublish English Journal Article

Inhibition of bile formation by high doses of taurocholate in the perfused rat liver.

Scandinavian journal of gastroenterology ·Vol. 11 ·No. 7 ·1976-00-00 ·Pages 741-6

Herz R, Paumgartner G, Preisig R

Abstract

Sodium taurocholate was administered to the in situ perfused liver of male Sprague Dawley rats at various rates below (57 and 114 nmol/min -g liver) and above (228 and 456 nmol/min -g liver) its biliary transport maximum (Tm) to study its effect on bile formation. As expected, bile flow increased with increasing dose until maximal bile salt excretion was reached. By contrast, during taurocholate infusions exceeding the taurocholate-Tm, bile flow and bile salt excretion decreased. Under those conditions, a given bile salt excretion was associated with a smaller volume of bile. A relationship between these effects and the concentration of taurocholate in the perfusate (160 to 860 nmol/ml) was suggested by the observation that bile formation returned toward normal when the taurocholate concentration was lowered by exchange of the perfusate.

MeSH Terms
Animals Bile/metabolism Bile Acids and Salts/biosynthesis,metabolism Dose-Response Relationship, Drug Liver/metabolism Male Perfusion Rats Secretory Rate/drug effects Taurocholic Acid/administration & dosage,pharmacology Time Factors
Chemicals
Bile Acids and Salts Taurocholic Acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Herz R
Paumgartner G
Preisig R
Article Info
Journal
Scandinavian journal of gastroenterology
Abbr.
Scand J Gastroenterol
ISSN
0036-5521
Published
1976-00-00
Pages
741-6
Language
English
Region
England
NLM ID
0060105
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com